Alnylam Netherlands B.V.
SpainAll drugs from this manufacturer
-
It is used to treat ATTR amyloidosis, a disease that can be hereditary or caused by aging, which occurs when the transthyretin (TTR) protein forms amyloid deposits in the body.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage vutrisiran 25 mg -
It is used to treat acute hepatic porphyria in adults and adolescents aged 12 years and older.
Dosage form: solution for injection
Active substance Dosage givosiran 200 mg/ml -
It is used to treat a hereditary disease called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), which is caused by problems with a protein called transthyretin (TTR). The medication helps reduce the amount of this protein produced by the liver to decrease the effects of the disease.
Dosage form: solution for infusion, concentrate
Active substance Dosage patisiran sodium 10,5 mg -
It is used to treat primary hyperoxaluria type 1 (PH1) in adults and children of any age. This disease causes the liver to produce an excess of oxalate, which can cause kidney stones and damage the kidneys, eyes, heart, skin, and bones.
Dosage form: solution for injection
Active substance Dosage lumasiran sodium 100 mg